Delivery Order SPE2DB20D1100-SPE2DB25FD5Q0
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,077.49 by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. The contractor's place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Lidocaine 5% Patch 30s, valued at $14,810.39. This competitively awarded, non-set-aside contract carries a firm fixed price arrangement with an ultimate completion date of July 28, 2025. The product will be delivered to the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $1,622.36, represents a non-competitive set-aside contract and is scheduled for completion by August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order, valued at $7,761.56, represents a non-competitive set-aside award and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30-count units, valued at $1,134.20. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $7,723.82. This firm fixed-price, non-set-aside contract is part of the company's broader relationship with the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies to support military and federal healthcare systems. The order is scheduled for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5Q0Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains a comprehensive product portfolio supporting military and veteran healthcare systems across multiple therapeutic domains. This delivery order falls under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The lidocaine patch procurement supports pain management requirements within the Defense Health Agency and broader military medical supply operations.